RightFit
RecruitingNot applicable

Kentucky - Quality Improvement Implementation Lung Cancer Screening (QUILS™) Health Services Research Intervention

Statewide Optimization of Lung Cancer Screening Utilizing the QUILS™ System (Kentucky QUILS™ Implementation): HSR Intervention

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years to 100 Years
Sex
All sexes
Healthy volunteers
Accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests whether the QUILS system can help Kentucky programs improve lung cancer screening, which checks for cancer. It is for team members and administrators at participating screening programs.

This clinical trial studies statewide optimization of lung cancer screening (LCS) in Kentucky using the Quality Implementation of Lung Screening (QUILS™) System. Data from the Kentucky Cancer Registry shows that LCS implementation has contributed to a rapid decline in late-stage lung cancer diagnosis at twice the national average. Further, the declines are more than three times the national average decline in Kentucky's Central Appalachian region. Kentucky-based multilevel initiatives are needed to expand and accelerate this leading role and extend the LCS opportunity to more Kentuckians who are at increased risk of lung cancer. This trial may be able to accelerate optimal high-quality implementation of LCS utilizing the QUILS™ System and reduce the burden of lung cancer by assisting lung cancer screening programs located throughout Kentucky in implementing best practices in lung cancer screening by integrating the QUILS™ System domains and elements into their screening programs.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Be a team member or administrator at a participating lung cancer screening program.
  • Be willing to take part in the QUILS survey process to assess the program.
  • Be willing to attend QUILS presentations that review the program and give feedback.
  • Be willing to take part in interviews to help evaluate and improve the project.

Who can't join

  • Not willing to take part in the QUILS survey process.
  • Not willing to attend QUILS presentations that review the program and give feedback.
  • Not willing to take part in interviews to help evaluate and improve the project.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * Member of a participating Lung Cancer Screening Program (LCSP) team or administrator * Willing to participate in the QUILS Index Assessment Survey process * Willing to participate in the QUILS Audit Feedback presentations * Willing to participate in formative evaluation interviews Exclusion Criteria: * Unwilling to participate in the QUILS Index Assessment Survey process * Unwilling to participate in the QUILS Audit Feedback presentations * Unwilling to participate in formative evaluation interviews

Study sites (17)

KY